Draft guideline on Guideline on core summary of product characteristics (SmPC) and package leaflet for iopamidol 300

  • Email
  • Help

Document details

Download document Draft guideline on Guideline on core summary of product characteristics (SmPC) and package leaflet for iopamidol 300
Reference number EMA/CHMP/813269/2016
Status draft: consultation open
First published 2017-04-26
Last updated 2017-04-26
Consultation start date 2017-04-26
Consultation end date 2017-08-31
Email address for submissions radiopharmaceuticalsdg@ema.europa.eu

Summary

This document describes the information to be included in the summary of product characteristics and package leaflet for iopamidol 300.